GCC Intravenous Solutions Market Share, Size, Growth, Opportunity and Forecast 2021-2026

*As the coronavirus disease (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

GCC Intravenous Solutions Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Market Overview:

The GCC intravenous solutions market is currently witnessing moderate growth. Intravenous (IV) solutions refer to a mix of chemically prepared fluids that are administered in the body through venous circulation. They are composed of medications and nutrients such as carbohydrates, amino acids, salts, electrolytes, vitamins, and minerals. IV solutions provide nutrients to patients suffering from cancer, diabetes, immune deficiencies, heart failure and other related diseases. In the GCC region, the demand for intravenous therapy has escalated as it offers rapid onset of drug effects compared to other drug delivery systems.

The GCC intravenous solutions market is primarily driven by the growing cases of gastrointestinal disorders, AIDS, obesity, and diabetes in the region. Apart from this, governments of several GCC countries, like Saudi Arabia, Oman and Qatar, are undertaking initiatives to offer better healthcare facilities to the people, which has increased the demand for IV solutions in the region. Besides this, the introduction of new intravenous solution products for different diseases and the treatment of dehydration is catalyzing the growth of the market. Furthermore, the faster response time and the rapid onset of drugs offered in the IV solution therapy are significant factors contributing to the market growth. Looking forward, IMARC Group expects the market to continue its moderate growth during the forecast period (2021-2026).

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the GCC intravenous solutions market report, along with forecasts for growth at the region level from 2021-2026. Our report has categorized the market based on region, type and nutrients.

Breakup by Type:

Partial Parenteral Nutrition
Total Parenteral Nutrition

Breakup by Nutrients:

Carbohydrates
Salts and Electrolytes
Minerals
Vitamins
Amino Acids

Breakup by Country:

Saudi Arabia
UAE
Qatar
Oman
Oman
Bahrain

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players.

Key Questions Answered in This Report:

How has the GCC intravenous solutions market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the GCC intravenous solutions market?
What are the key regional markets?
What is the breakup of the market based on the type?
What is the breakup of the market based on the nutrients?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the GCC intravenous solutions market and who are the key players?
What is the degree of competition in the industry?